Southern American Branch of the Iberoamerican Cochrane Centre, Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina.
Fertil Steril. 2012 Dec;98(6):1539-43. doi: 10.1016/j.fertnstert.2012.08.018. Epub 2012 Sep 12.
To evaluate the level of evidence published in infertility journals with the highest impact factors.
Systematic review. We searched in PubMed identifying potential systematic reviews with meta-analysis (SRs) and randomized controlled trials (RCTs) between 2006 and 2010 in the five fertility journals with highest impact factor.
Academic institution.
PATIENT(S): None.
INTERVENTION(S): None.
MAIN OUTCOMES MEASURE(S): Number and proportion of potential SRs and RCTs published in 2006-2011, and quality assessment of real RCTs published in 2010.
RESULT(S): Among evaluated articles, 1.5% and 6.8% were SRs and RCTs. Fertility and Sterility has been the journal with more potential SRs and RCTs, and Human Reproduction Update was the only one with an increasing trend in the number of potential SRs (from 5.3% in 2006 to 24.4% in 2011). Among confirmed RCTs, for each quality assessment item, between 50% and 85% were classified as having low risk of bias, and the most common high risk of bias was related to allocation concealment. Only 23% had a trial registration, which were associated with higher quality assessment classifications. Only 10% of RCTs reported pharmaceutical industry funding.
CONCLUSION(S): This is the first study assessing the methodologic quality of publications in the top five fertility journals. More than 90% of all the publications were neither SRs nor RCTs. It is remarkable that the risk of bias was generally low. Enhancing trial registration and funding source statements represent opportunities to improve the quality of reporting. We hope this information is useful to researchers, editorial boards, and clinicians moving forward with research in our field.
评估影响因子最高的不孕不育期刊发表的文献的证据水平。
系统评价。我们在 PubMed 中检索了 2006 年至 2010 年期间发表的具有系统评价(SR)和随机对照试验(RCT)的潜在系统评价,这些研究来自五个影响因子最高的生育期刊。
学术机构。
患者/参与者:无。
无。
2006-2011 年发表的潜在 SR 和 RCT 的数量和比例,以及 2010 年发表的真实 RCT 的质量评估。
在评估的文章中,1.5%和 6.8%为 SR 和 RCT。《生育与不孕》一直是发表潜在 SR 和 RCT 最多的期刊,而《人类生殖更新》是唯一发表的潜在 SR 数量呈上升趋势的期刊(从 2006 年的 5.3%上升到 2011 年的 24.4%)。在确认的 RCT 中,每个质量评估项目都有 50%到 85%被归类为低偏倚风险,最常见的高偏倚风险与分配隐藏有关。只有 23%的 RCT 进行了试验注册,且与更高的质量评估分类相关。只有 10%的 RCT 报告了制药行业的资助。
这是第一项评估五大生育期刊发表文献的方法学质量的研究。超过 90%的出版物既不是 SR 也不是 RCT。值得注意的是,偏倚风险通常较低。加强试验注册和资金来源的声明是提高报告质量的机会。我们希望这些信息对研究人员、编辑委员会和临床医生在我们的领域开展研究有所帮助。